482200 Sigma-AldrichNimodipine - CAS 66085-59-4 - Calbiochem
An L-type Ca2+ channel blocker.
More>> An L-type Ca2+ channel blocker. Less<<Synonyms: 1,4-Dihydro-2,6-dimethyl-4-(3ʹ-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl-1-methylethyl Ester
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
66085-59-4 | C₂₁H₂₆N₂O₇ |
Products
Catalogue Number | Packaging | Qty/Pack | |
---|---|---|---|
482200-25MG | Plastic ampoule | 25 mg |
Product Information | |
---|---|
CAS number | 66085-59-4 |
ATP Competitive | N |
Form | Yellow solid |
Hill Formula | C₂₁H₂₆N₂O₇ |
Chemical formula | C₂₁H₂₆N₂O₇ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | L-type Ca2+ channel blocker |
Primary Target IC<sub>50</sub> | 36 pM blocking TNF-α and LPS-induced iNOS activity in mouse astroglial cells |
Purity | >98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | US7975500 |
Safety Information | |
---|---|
R Phrase | R: 20/21/22 Harmful by inhalation, in contact with skin and if swallowed. |
S Phrase | S: 36 Wear suitable protective clothing. |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
482200-25MG | 04055977183498 |
Documentation
Nimodipine - CAS 66085-59-4 - Calbiochem SDS
Title |
---|
Nimodipine - CAS 66085-59-4 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
482200 |
References
Reference overview |
---|
Zhu, D., et al. 1999. Life. Sci. 65, PL 221. Marchetti, C. and Usai, C. 1996. Neurosci. Lett. 207, 77. Kappelle, A.C., et al. 1994. Br. J. Pharmacol. 111, 887. Weiss, J.H., et al. 1994. J. Neurochem. 62, 372. Kappelle, A.C., et al. 1993. Br. J. Pharmacol. 108, 780. |